These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9674047)

  • 21. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of early rebleeding.
    Roos Y; Vermeulen M
    J Neurosurg; 2003 May; 98(5):1148-9; author reply 1149-50. PubMed ID: 12744388
    [No Abstract]   [Full Text] [Related]  

  • 24. Foreword.
    Jones GM
    Crit Care Nurs Q; 2020; 43(2):107-108. PubMed ID: 32084056
    [No Abstract]   [Full Text] [Related]  

  • 25. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.
    Vergouwen MD; Vermeulen M; Coert BA; Stroes ES; Roos YB
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1761-70. PubMed ID: 18628782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of radiographically impending stroke with multiple intraarterial papaverine infusions in severe diffuse cerebral vasospasm induced by subarachnoid hemorrhage.
    Liu JK; Tenner MS; Oestreich HM; Couldwell WT
    Acta Neurochir (Wien); 2001 Dec; 143(12):1249-55; discussion 1256. PubMed ID: 11810389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental approaches to evaluate endothelin-A receptor antagonists.
    Vatter H; Zimmermann M; Seifert V; Schilling L
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):277-86. PubMed ID: 15319806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of vascular dysfunction after subarachnoid hemorrhage.
    Koźniewska E; Michalik R; Rafałowska J; Gadamski R; Walski M; Frontczak-Baniewicz M; Piotrowski P; Czernicki Z
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():145-60. PubMed ID: 17244946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage.
    Kramer AH; Gurka MJ; Nathan B; Dumont AS; Kassell NF; Bleck TP
    Crit Care Med; 2008 Jul; 36(7):2070-5. PubMed ID: 18552682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stellate ganglion block as alternative to intrathecal papaverine in relieving vasospasm due to subarachnoid hemorrhage.
    Prabhakar H; Jain V; Rath GP; Bithal PK; Dash HH
    Anesth Analg; 2007 May; 104(5):1311-2. PubMed ID: 17456713
    [No Abstract]   [Full Text] [Related]  

  • 31. L-arginine improves cerebral blood perfusion and vasomotion of microvessels following subarachnoid hemorrhage in rats.
    Sun BL; Zhang SM; Xia ZL; Yang MF; Yuan H; Zhang J; Xiu RJ
    Clin Hemorheol Microcirc; 2003; 29(3-4):391-400. PubMed ID: 14724366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive care unit management of interventional neuroradiology patients.
    Connolly ES; Lavine SD; Meyers PM; Palistrandt D; Parra A; Mayer SA
    Neurosurg Clin N Am; 2005 Jul; 16(3):541-5, vi. PubMed ID: 15990043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.
    Muroi C; Terzic A; Fortunati M; Yonekawa Y; Keller E
    Surg Neurol; 2008 Jan; 69(1):33-9; discussion 39. PubMed ID: 18054611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endovascular treatment of subarachnoid hemorrhage.
    Kirmani JF; Alkawi A; Ahmed S; Janjua N; Khatri I; Divani AA; Qureshi AI
    Neurol Res; 2005; 27 Suppl 1():S103-7. PubMed ID: 16197834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simvastatin in subarachnoid haemorrhage: beyond the short-term.
    Lombard F; Britz GW; Warner DS
    Lancet Neurol; 2014 Nov; 13(11):1073. PubMed ID: 25316014
    [No Abstract]   [Full Text] [Related]  

  • 36. Simvastatin in subarachnoid haemorrhage: beyond the short-term--authors' reply.
    Kirkpatrick PJ; Turner CL
    Lancet Neurol; 2014 Nov; 13(11):1073-1074. PubMed ID: 25316013
    [No Abstract]   [Full Text] [Related]  

  • 37. Radioimmunoassay for leukotrienes: some applications and limitations.
    Levine L
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():339-51. PubMed ID: 2949559
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cerebroprotection--catchword or therapeutic concept?].
    Krier C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 May; 26(3):123-5. PubMed ID: 1873420
    [No Abstract]   [Full Text] [Related]  

  • 39. [The concept of "hemorrhage-ischemia" and its therapeutic applications].
    Tellería-Díaz A; García OD; Sánchez-Chávez JJ
    Rev Neurol; 1998 Jul; 27(155):160-1. PubMed ID: 9674047
    [No Abstract]   [Full Text] [Related]  

  • 40. Artificial oxygen carriers and the cerebral circulation.
    Lenz C; Waschke F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S110-3. PubMed ID: 11753713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.